Stanley Chaleff

2.0k total citations · 1 hit paper
8 papers, 1.5k citations indexed

About

Stanley Chaleff is a scholar working on Hematology, Immunology and Genetics. According to data from OpenAlex, Stanley Chaleff has authored 8 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Hematology, 4 papers in Immunology and 2 papers in Genetics. Recurrent topics in Stanley Chaleff's work include Acute Myeloid Leukemia Research (3 papers), Immune Cell Function and Interaction (3 papers) and Acute Lymphoblastic Leukemia research (2 papers). Stanley Chaleff is often cited by papers focused on Acute Myeloid Leukemia Research (3 papers), Immune Cell Function and Interaction (3 papers) and Acute Lymphoblastic Leukemia research (2 papers). Stanley Chaleff collaborates with scholars based in United States and Germany. Stanley Chaleff's co-authors include Rupert Handgretinger, Stephen D. Gillies, Leonard D. Shultz, Lisa Burzenski, Malak Kotb, Dale L. Greiner, Bonnie Lyons, Bruce Gott, Xiaohua Chen and Marie King and has published in prestigious journals such as Blood, The Journal of Immunology and Clinical Cancer Research.

In The Last Decade

Stanley Chaleff

8 papers receiving 1.5k citations

Hit Papers

Human Lymphoid and Myeloid Cell Development in NOD/LtSz- ... 2005 2026 2012 2019 2005 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stanley Chaleff United States 7 679 468 437 361 247 8 1.5k
Marie King Ireland 6 711 1.0× 459 1.0× 437 1.0× 267 0.7× 317 1.3× 13 1.6k
Ignazia Prigione Italy 30 1.6k 2.3× 768 1.6× 615 1.4× 298 0.8× 184 0.7× 75 2.5k
Thomas Eiermann Germany 25 1.0k 1.5× 434 0.9× 362 0.8× 361 1.0× 244 1.0× 65 2.0k
Shuro Yoshida Japan 16 969 1.4× 602 1.3× 669 1.5× 775 2.1× 228 0.9× 67 2.4k
Joseph Laning United States 19 1.2k 1.8× 569 1.2× 330 0.8× 200 0.6× 312 1.3× 28 1.9k
Myriam Armant United States 28 1.1k 1.5× 376 0.8× 720 1.6× 189 0.5× 215 0.9× 55 2.2k
Ikumi Katano Japan 18 934 1.4× 482 1.0× 312 0.7× 168 0.5× 292 1.2× 39 1.5k
Chozhavendan Rathinam United States 16 1.0k 1.5× 323 0.7× 694 1.6× 390 1.1× 550 2.2× 23 2.0k
Loren D. Erickson United States 26 1.7k 2.5× 472 1.0× 514 1.2× 360 1.0× 131 0.5× 41 2.5k
Eric Braakman Netherlands 24 801 1.2× 421 0.9× 279 0.6× 329 0.9× 124 0.5× 63 1.3k

Countries citing papers authored by Stanley Chaleff

Since Specialization
Citations

This map shows the geographic impact of Stanley Chaleff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stanley Chaleff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stanley Chaleff more than expected).

Fields of papers citing papers by Stanley Chaleff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stanley Chaleff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stanley Chaleff. The network helps show where Stanley Chaleff may publish in the future.

Co-authorship network of co-authors of Stanley Chaleff

This figure shows the co-authorship network connecting the top 25 collaborators of Stanley Chaleff. A scholar is included among the top collaborators of Stanley Chaleff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stanley Chaleff. Stanley Chaleff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Chaleff, Stanley, Craig A. Hurwitz, Myron Chang, et al.. (2011). Phase II study of 2‐chlorodeoxyadenosine plus idarubicin for children with acute myeloid leukaemia in first relapse: a Paediatric Oncology Group study. British Journal of Haematology. 156(5). 649–655. 9 indexed citations
2.
Jacobsohn, David A., William Tse, Stanley Chaleff, et al.. (2009). High WT1 gene expression before haematopoietic stem cell transplant in children with acute myeloid leukaemia predicts poor event‐free survival. British Journal of Haematology. 146(6). 669–674. 51 indexed citations
3.
Rosenfeld, Amy, Daniel L. Schwartz, Steven Garzon, & Stanley Chaleff. (2009). Epithelial-Myoepithelial Carcinoma of the Lung. Journal of Pediatric Hematology/Oncology. 31(3). 206–208. 17 indexed citations
4.
Chaleff, Stanley, Mario Otto, Raymond Barfield, et al.. (2007). A large-scale method for the selective depletion of αβ T lymphocytes from PBSC for allogeneic transplantation. Cytotherapy. 9(8). 746–754. 77 indexed citations
5.
Hijiya, Nobuko, Paul S. Gaynon, Manuel Castro‐Fernández, et al.. (2007). A Novel Therapy of Clofarabine in Combination with Etoposide and Cyclophosphamide Shows Activity in Pediatric Patients with Refractory or Relapsed Acute Leukemia.. Blood. 110(11). 883–883. 1 indexed citations
6.
Shultz, Leonard D., Bonnie Lyons, Lisa Burzenski, et al.. (2005). Human Lymphoid and Myeloid Cell Development in NOD/LtSz- scid IL2R γ null Mice Engrafted with Mobilized Human Hemopoietic Stem Cells,. The Journal of Immunology. 174(10). 6477–6489. 1305 indexed citations breakdown →
7.
Otto, Mario, Raymond Barfield, Martin Wj, et al.. (2005). Combination Immunotherapy with Clinical-Scale Enriched Human γδ T cells, hu14.18 Antibody, and the Immunocytokine Fc-IL7 in Disseminated Neuroblastoma. Clinical Cancer Research. 11(23). 8486–8491. 36 indexed citations
8.
Shultz, Leonard D., Bonnie Lyons, Lisa Burzenski, et al.. (2004). Human Lymphoid and Myeloid Cell Development in NOD/LtSz-scid IL2rγnull Mice Engrafted with Mobilized Human Hematopoietic Stem Cells.. Blood. 104(11). 248–248. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026